What is the purpose of a Gastrografin (diatrizoate) enema after an ileostomy placement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Purpose of Gastrografin Enema After Ileostomy Placement

A Gastrografin (water-soluble contrast) enema after ileostomy placement is performed to evaluate the integrity of the distal anastomosis prior to ileostomy reversal, specifically to detect anastomotic leaks, strictures, fistulas, or sinus tracts that would contraindicate stoma closure. 1

Primary Indications

The water-soluble contrast enema serves several diagnostic purposes in the post-ileostomy setting:

Detection of Anastomotic Complications

  • Anastomotic leaks: The contrast demonstrates extraluminal extravasation, confirming leak presence with sensitivity of 50% and specificity of 96.8% 1
  • Strictures: Detects clinically significant occult strictures in 14% of patients prior to ileostomy takedown, with sensitivity of 80% for small-bowel and inlet strictures 1
  • Fistulas and sinus tracts: Identifies abnormal communications with sensitivity of 33.3% for fistulas and 50% for sinus tracts 1

Timing and Protocol

The examination is typically performed prior to ileostomy reversal to ensure the distal anastomosis has healed adequately. 2 For enemas, Gastrografin should be diluted: 240 mL (88 g iodine) in 1,000 mL of tap water for adults 2

Evidence-Based Controversy

The routine use of this examination is controversial and may not be necessary in all patients:

Arguments Against Routine Use

  • In patients without clinical suspicion of anastomotic problems, the incidence of positive radiological leak is low (5.8%) 3
  • Studies show that pathology detected by water-soluble contrast enema is equally detected on digital rectal examination and endoscopy, suggesting selective rather than routine use 1
  • One study found that routine use does not impact ileostomy takedown decisions compared with clinical examination and endoscopy 1

Arguments for Selective Use

The examination should be selectively used when:

  • Postoperative leak or complications occurred 4
  • Cancer patients (10% leak rate vs 2% in non-cancer patients) 4
  • Patients who had immediate postoperative complications 4
  • Clinical suspicion of anastomotic failure exists 3

Clinical Algorithm

Recommend water-soluble contrast enema if:

  1. History of postoperative anastomotic leak or complications
  2. Rectal cancer resection (higher risk population)
  3. Clinical signs suggesting anastomotic problems (pain, fever, drainage)
  4. Chemoradiotherapy received

Consider omitting if:

  1. Uncomplicated postoperative course
  2. Non-cancer resections
  3. Normal digital rectal examination and endoscopy

Important Caveats

  • Water-soluble contrast is preferred over barium to avoid peritoneal contamination if perforation exists 1
  • CT with rectal contrast may be superior to fluoroscopic enema for detecting leaks (89.5% vs 40% positive predictive value) 1
  • A positive radiological leak without clinical symptoms may represent a false positive—some patients proceed to reversal successfully despite positive findings 3
  • The examination has limited sensitivity for proximal anastomoses 5

The decision to perform routine versus selective water-soluble contrast enema should prioritize patient safety by identifying high-risk patients (cancer, prior complications) while avoiding unnecessary testing in uncomplicated cases where clinical examination and endoscopy are normal.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.